Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Intravenous to Oral Antibiotic Switch in Uncomplicated Staphylococcus Aureus Bacteraemia: The EVOS Randomized Controlled Trial

NCT06336824 is registered in ClinicalTrials.gov with Clinical Research Centre, Malaysia as lead sponsor.

NCT NCT06336824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06336824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Intravenous to Oral Antibiotic Switch in Uncomplicated Staphylococcus Aureus Bacteraemia: The EVOS Randomized Controlled Trial
Lead sponsor
Clinical Research Centre, Malaysia
Phase
Phase 3
Overall status
Unknown status
Start date
June 28, 2024
Completion date
June 30, 2025
Enrollment
290 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

staphylococcus aureus bacteremia